Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

U. of Colorado team developing ’Flu Chip’ for fast, accurate diagnosis

11.11.2003


From left to right, CU-Boulder Associate Professor Robert Kuptcha, undergraduate student Amy Reppert, graduate student Michael Townsend and team leader and Professor Kathy Rowlen of the chemistry and biochemistry department. Photo courtesy of Casey Cass, University of Colorado. The Flu Chip image was accessed from the website of Leming Shi of Jefferson, Ark.


A team of researchers at the University of Colorado at Boulder is developing a "Flu Chip" that will aid physicians in swiftly diagnosing respiratory illness for future flu seasons.

The Flu Chip will allow doctors and public health officials to differentiate between three types of influenza and other viruses that cause similar clinical symptoms, such as severe acute respiratory syndrome, or SARS.

The CU team, led by Professor Kathy Rowlen and co-principal investigator and Associate Professor Robert Kuchta of the chemistry and biochemistry department, recently received a $1.7 million grant from the National Institute of Infectious Disease to develop the chip in collaboration with the Centers for Disease Control and Prevention in Atlanta, the World Health Organization and Bio-Rad Laboratories in Hercules, Calif.



According to Rowlen, influenza A viral infections have had a dramatic impact on humans, with an estimated 500,000 deaths worldwide each year and significant economic impact resulting from direct and indirect loss of productivity during infection.

"For comparison, the corona virus that caused the recent outbreak of SARS has claimed less than 1,000 lives to date," said Rowlen. "However, as demonstrated by the public response to SARS, of great concern is the ability of viruses to undergo natural or engineered genetic change that could result in a virus capable of rapid and lethal spread within the population."

One of the most dramatic events in influenza history was the so-called "Spanish Flu" pandemic of 1918-1919. In less than a year, between 20 million and 40 million people died from influenza, with an estimated one fifth of the world’s population infected.

"Because it is readily transmitted, primarily as an airborne pathogen and because the virus can be genetically engineered into novel forms, influenza A also represents a serious biodefense concern," Rowlen said.

"Rapid identification of any biological pathogen, such as flu A, anthrax or SARS, requires a reliable and relatively inexpensive analytical system that can be widely manufactured and distributed," she said. "Current commercial technology for rapid identification of influenza A does not provide any genetic information and therefore cannot provide investigators at the CDC or the World Health Organization with adequate information for managing local epidemics or worldwide pandemics."

DNA microarrays, which are the basis for the Flu Chip, represent a promising technology for accurate and relatively rapid pathogen identification based on genetic "signatures."

The general structure of a DNA microarray is a well-defined arrangement of micron-sized spots on an optically flat surface, each of which contains a layer of relatively short strands of DNA designed to capture a specific genetic sequence from a sample.

Each spot -- about one-thousandth of an inch across -- is deposited by a robot. Patient samples can be evaluated through a fairly simple procedure called hybridization. Hybridization is achieved by heating and slowly cooling the sample processed from a patient with the microarray.

The microarray is then developed to produce an image, she said. By knowing the identity of specific DNA segments known as oligonucleotides at any location within the array, one can determine which bits of genetic information were present in the patient sample by reading the image.

The CU team of researchers is developing the Flu Chip as an inexpensive way to swiftly -- within an hour or less -- screen for influenza A, the most bothersome strain of flu, as well as influenza B and C, SARS and respiratory syncytial virus, which is a primary cause of respiratory illness in infants. "In addition, the Flu Chip could play a significant role in detecting and containing viral outbreaks or alerting officials to an ’engineered’ influenza virus," Rowlen said.

Other members of the CU-Boulder Flu Chip team include post-doctoral research associate Chad Moore, graduate students Michael Townsend and James Smagala, and undergraduate student Amy Reppert.

"In order to address the needs in developing nations, one of our primary objectives is to create an inexpensive and field-portable test kit for respiratory illness," said Rowlen. "The goal is to provide an important new tool to the World Health Organization for global screening of respiratory illness," she said.

Kathy Rowlen | CU-Boulder
Further information:
http://www.colorado.edu/news/
http://www.colorado.edu/news/releases/2003/434.html

More articles from Life Sciences:

nachricht Researchers identify potentially druggable mutant p53 proteins that promote cancer growth
09.12.2016 | Cold Spring Harbor Laboratory

nachricht Plant-based substance boosts eyelash growth
09.12.2016 | Fraunhofer-Institut für Angewandte Polymerforschung IAP

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electron highway inside crystal

Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.

Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Researchers identify potentially druggable mutant p53 proteins that promote cancer growth

09.12.2016 | Life Sciences

Scientists produce a new roadmap for guiding development & conservation in the Amazon

09.12.2016 | Ecology, The Environment and Conservation

Satellites, airport visibility readings shed light on troops' exposure to air pollution

09.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>